Stimcell Energetics (STME) EPS (Basic) Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | Stimcell Energetics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 0.00% |
| May 31, 2025 | 0.00% |
| Feb 28, 2025 | -133.33% |
| Nov 30, 2024 | 0.00% |
| Feb 29, 2024 | 150.78% |
| Nov 30, 2023 | -340.60% |
| Aug 31, 2023 | 50.25% |
| Feb 28, 2023 | -3,011.19% |
| Nov 30, 2022 | 18.85% |
| Aug 31, 2022 | 35.88% |
| May 31, 2022 | -444.05% |
| Feb 28, 2022 | 80.76% |
| Nov 30, 2021 | 72.86% |
| Aug 31, 2021 | -8.11% |
| May 31, 2021 | 25.09% |
| Feb 28, 2021 | 1.28% |
| Nov 30, 2020 | -3.05% |
| Aug 31, 2020 | 64.54% |
| May 31, 2020 | 77.48% |
| Feb 29, 2020 | 0.00% |
| Nov 30, 2019 | -462.32% |
| Aug 31, 2019 | 0.00% |
| May 31, 2019 | -492.72% |
| Feb 28, 2019 | 0.00% |
| Aug 31, 2018 | 50.00% |
| May 31, 2018 | -150.00% |
| Feb 28, 2018 | 0.00% |
| Aug 31, 2017 | -100.00% |
| May 31, 2017 | 300.00% |
| Feb 28, 2017 | 0.00% |